There is provided a complex for use as a therapeutic pharmaceutical, the complex has a ligand containing at least one hydroxyalkyl phosphine donor group bound to a gold atom to form a stable gold-ligand complex. More specifically, the present invention relates to optically active quinoline carboxylic acid derivatives containing 4-aminomethyl-4-methyl-3–alkoxyirninopyrrolidine substituents causing optical activity at the 7-position of the quinolone nuclei. The layer are capable of including an aperture that exposes a portion of the underlayer. Motion compensation for the downsampled image is performed in the spatial domain. Then, they are converted to the frequencies of the transmission channels.